Kaoru Hatano

Bortezomib overcomes cell adhesion-mediated drug resistance through downregulation of VLA-4 expression in multiple myeloma

Kaoru Hatano, Jiro Kikuchi, Masaaki Takatoku et al. · Oncogene · 2008 · 187 citations

Hematological Malignancy, Adhesion-mediated Drug Resistance, Immunology +7

Rituximab plus 70% cyclophosphamide, doxorubicin, vincristine and prednisone for Japanese patients with diffuse large B-cell lymphoma aged 70 years and older

Akiko Meguro, Katsutoshi Ozaki, Kazuya Sato et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2011 · 43 citations

Analysis of the cost-effectiveness of treatment strategies for CML with incorporation of treatment discontinuation

Chihiro Yamamoto, Hirotomo Nakashima, Takashi Ikeda et al. · Blood Advances · 2019 · 37 citations · Full text

Comparison of gabexate mesilate and nafamostat mesilate for disseminated intravascular coagulation associated with hematological malignancies

Daisuke Minakata, Shin‐ichiro Fujiwara, Takashi Ikeda et al. · International Journal of Hematology · 2018 · 36 citations

Thrombosis, Venous Thrombosis, Laboratory Hematology +12

Comprehensive Analysis of the Activation and Proliferation Kinetics and Effector Functions of Human Lymphocytes, and Antigen Presentation Capacity of Antigen-Presenting Cells in Xenogeneic Graft-Versus-Host Disease

Yasufumi Kawasaki, Kazuya Sato, Hiroko Hayakawa et al. · Biology of Blood and Marrow Transplantation · 2018 · 31 citations · Full text